Compare HDFC Pharma And Healthcare Fund vs ICICI Prudential Healthcare Fund
HDFC Pharma And Healthcare Fund
EquitySectoral-Pharma
ICICI Prudential Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.13
2.07
NAV
₹21.23
₹44.81
Fund Started
14 Sep 2023
25 Jun 2018
Fund Size
₹3501.37 Cr
₹6861.20 Cr
Exit Load
Exit load of 1%, if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year
18.60%
2.11%
3 Year
26.91%
19.35%
5 Year
-
13.95%
Equity
96.77%
98.91%
Cash
3.23%
1.09%
Top 10 Holdings
Name | Assets |
|---|---|
Divi's Laboratories Ltd. | 9.39% |
Sun Pharmaceutical Industries Ltd. | 8.28% |
Alkem Laboratories Ltd. | 4.64% |
Cipla Ltd. | 4.15% |
Apollo Hospitals Enterprise Ltd. | 3.69% |
Torrent Pharmaceuticals Ltd. | 3.65% |
Max Healthcare Institute Ltd. | 3.61% |
Aster DM Quality Care Ltd. | 3.56% |
Lupin Ltd. | 3.55% |
Neuland Laboratories Ltd. | 3.24% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.49% |
Dr. Reddy's Laboratories Ltd. | 9.73% |
Cipla Ltd. | 5.79% |
Biocon Ltd. | 5.33% |
Mankind Pharma Ltd. | 5.04% |
Alkem Laboratories Ltd. | 4.81% |
Medplus Health Services Ltd. | 4.31% |
Cohance Lifesciences Ltd. | 4.06% |
Divi's Laboratories Ltd. | 3.78% |
Syngene International Ltd. | 3.50% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
14 Sep 2023
25 Jun 2018
